Account
Case Studies
26.04.2023
Development of an EU go-to-market access plan

Our client is developing best-in-class antibodies to neutralise coronaviruses. Our client wanted to...

Read more
News
25.04.2023
PMA Insights: Week 17

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
25.04.2023
EU aims to revamp European pharmaceutical laws

With country health budgets drained following the pandemic, the European Commission aims to reform E...

Read more
News
30.03.2023
PMA Insights: Week 13 SPECIAL EDITION – Worl...

We summarise the World EPA Congress 2023 including plenary sessions on EU HTA, market archetypes, he...

Read more
News
15.03.2023
PMA Insights: Week 11

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Insider Insights
14.03.2023
Newly agreed Windsor Framework carries significant...

Windsor Framework replaces the Northern Ireland protocol to address issues and provide significant c...

Read more
Insider Insights
09.03.2023
What has occurred in the past year in the Swedish ...

TLV unveils annual report, offering insights into trends and projects that have dominated the past y...

Read more
Insider Insights
09.03.2023
CMS declines to revise coverage for FDA-approved t...

CMS denies coverage of FDA-approved treatments that target amyloid for Alzheimer's disease unless th...

Read more
Insider Insights
02.03.2023
ABPI sets out new proposals in VPAG

ABPI announces new VPAG, which focuses on restoring the commercially competitive environment for lif...

Read more
Insider Insights
22.02.2023
NICE announces the development of a new rapid revi...

New process to assess clinical and cost-effectiveness of COVID-19 treatments to get these medicines ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.